Verteporfin inhibits PD-L1 through autophagy and the STAT1–IRF1–TRIM28 signaling axis, exerting antitumor efficacy
… Using reverse-phase protein arrays to assess drugs in use or likely to enter trials, we … for
inhibitors of PD-L1 expression and identified verteporfin as a possible small-molecule inhibitor. …
inhibitors of PD-L1 expression and identified verteporfin as a possible small-molecule inhibitor. …
[PDF][PDF] Verteporfin inhibits PD-L1 through autophagy and the STAT1-IRF1-TRIM28 signaling axis, exerting antitumor efficacy
SS Yu, XH Chen, M Gao, FX Claret, Z Ding, J Chen… - researchgate.net
… upstream of IRF1. To determine where in the STAT1 pathway verteporfin might be acting,
we performed IRF1 immunoprecipitation and found that whereas IFN-γ induced a marked …
we performed IRF1 immunoprecipitation and found that whereas IFN-γ induced a marked …
TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance
X Ma, S Jia, G Wang, M Liang, T Guo, H Du… - Signal transduction and …, 2023 - nature.com
… The autophagy-lysosome and ubiquitin-proteasome systems are … -AKT-mTOR signaling
pathway was significantly activated in … STAT1-IRF1-TRIM28 complex, 27 confirming that TRIM28 …
pathway was significantly activated in … STAT1-IRF1-TRIM28 complex, 27 confirming that TRIM28 …
Reducing PD-L1 Expression by Degraders and Downregulators as a Novel Strategy to Target the PD-1/PD-L1 Pathway
Z Wang, L Yuan, X Liao, X Guo… - Journal of Medicinal …, 2024 - ACS Publications
… level via the STAT3 signaling pathway in MIA PaCa-2 and … identified in 2020 that
verteporfin, a photosensitizer commonly … -related autophagy and disrupting the STAT1-IRF1-TRIM28-…
verteporfin, a photosensitizer commonly … -related autophagy and disrupting the STAT1-IRF1-TRIM28-…
BRD4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells
… levels of PD-L1 under verteporfin treatment. Verteporfin reduced the transcript and protein
levels of … of PD-L1 by targeting PD-L1 using siRNA, BRD4 inhibitors (JQ1 and ARV-825), and …
levels of … of PD-L1 by targeting PD-L1 using siRNA, BRD4 inhibitors (JQ1 and ARV-825), and …
Cancer immunotherapeutic challenges from autophagy-immune checkpoint reciprocal regulation
G Zhang, Y Chen, X Huang, T Liang - Trends in Cancer, 2024 - cell.com
… Verteporfin, a photosensitizing agent primarily used in … through the activation of ERK/TTP
and p38/STAT3/IRF1 … -intrinsic PD-L1 pathway partially suppresses the basal autophagic flux …
and p38/STAT3/IRF1 … -intrinsic PD-L1 pathway partially suppresses the basal autophagic flux …
Autophagy as a target for non-immune intrinsic functions of programmed cell death-ligand 1 in cancer
BE García-Pérez, C Pérez-Torres… - International Journal of …, 2023 - mdpi.com
… functions of PD-L1 and its potential influence on autophagy, … and activator of transcription
(JAK/STAT1) pathways, as crucial … main signaling pathway involved in the regulation of PD-L1 …
(JAK/STAT1) pathways, as crucial … main signaling pathway involved in the regulation of PD-L1 …
Autophagy controls programmed death‑ligand 1 expression on cancer cells
L Gao, Y Chen - Biomedical Reports, 2021 - spandidos-publications.com
… To be specific, obstructing the PD-L1/PD-1 signalling pathway by antibodies … PD-L1 expression
via activation of the STAT1 signalling … of PD-L1 induced by verteporfin was reversed (50). …
via activation of the STAT1 signalling … of PD-L1 induced by verteporfin was reversed (50). …
Verteporfin synergizes the efficacy of anti-PD-1 in cholangiocarcinoma
… immune microenvironment partially through targeting CSCs via inhibition of YAP1 and …
VP inhibits PD-L1 expression through autophagy and the STA1/IRF1/TRIM28 signaling axis …
VP inhibits PD-L1 expression through autophagy and the STA1/IRF1/TRIM28 signaling axis …
900 Depleting non-canonical, cell-intrinsic PD-L1 signals induces synthetic lethality to small molecule DNA damage response inhibitors in an immune independent …
… Verteporfin inhibits PD-L1 through autophagy and the STAT1-IRF1-TRIM28 signaling axis,
exerting antitumor efficacy. Cancer Immunol Res 8:952–965, doi:10.1158/2326-6066.CIR-19-…
exerting antitumor efficacy. Cancer Immunol Res 8:952–965, doi:10.1158/2326-6066.CIR-19-…